Abstract
In this study by using the human recombinant non-pancreatic-secreted platelet PLA2 (r-hnps-PLA2) and rabbit polyclonal antibodies directed against either the human (group II) or the porcine enzyme (group I), we have shown a possible involvement of platelet PLA2 in poly-l-arginine (25 kDa)-induced rat paw edema. Local treatment of rats with the anti-platelet-PLA2 antibody (anti-hnps-PLA2) but not with anti-porcine-PLA2 antibody (anti-porc-PLA2) significantly reduced the edema induced by a maximal dose of poly-l-arginine (1 mg/paw). Furthermore when r-hnps-PLA2 (1–10μg) was injected together with a subliminal dose of poly-l-arginine (50μg/paw), a dose-dependent increase in both edema and protein leakage was observed. This effect was selectively inhibited by the anti-hnps-PLA2 (10–100μg/paw) but not anti-porc-PLA2 (10–100 μg paw). Thus, platelets seem to be involved in both vascular and cellular components of the inflammatory response by contributing, most likely in the early phase, to the edema formation through secretion of PLA2.
Similar content being viewed by others
References
Clark, J. D., L. L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. L. Lin, N. Milona, andJ. L. Knopf. 1991. A novel arachidonic acid selective cytosolic PLA2 contains a calcium dependent translocation domain with homology to PKC and GAP.Cell 65:1043–1045.
Kramer, R. M., E. F. Roberts, J. Manetta, andJ. E. Putnam. 1991. The calcium sensitive cytosolic PLA2 is a 100-kDa protein in human monoblast U937 cells.J. Biol. Chem. 266:5628–5272.
Horigome, K., K. Hayakawa, K. Inoue, andS. Nojima. 1987. Selective release of phospholipase A2 and lysophosphatidylserine specific lysophospholipase from rat platelets.J. Biochem. 101:53–61.
Vadas, P., andJ. B. Hay. 1980. The release of phospholipase A2 from aggregated platelets and stimulated macrophages of sheep.Life Sci. 26:1721–1725.
Kramer, R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, andR. B. Pepinsky. 1989. Structure and properties of a human nonpancreatic phospholipase A2.J. Biol. Chem. 264:5768–5775.
Davidson, F. F., andE. A. Dennis. 1990. Evolutionary relationships and implications for the regulation of phospholipase A2: From snake venom to human secreted forms.J. Mol. Evol. 31:228–232.
Bomalaski, J. S., P. Lawton, andJ. L. Browning. 1991. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints.J. Immunol. 146:3904–3910.
Kini, R. M., andH. J. Evans. 1980. Structure-function relationship of phospholipases. The anticoagulant region of phospholipase A2.J. Biol. Chem. 255:7734–7737.
Elsabach, P., J. Weiss, andS. Forst. 1986.In Lipids and Membranes. J. A. F. Op den Kamp, B. Roelofse, and K. W. A. Wirtz, editors. Elsevier Science Publishers, Amsterdam. 259.
Vadas, P., W. Pruzanski, J. Kim, andV. Fornasier. 1989. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.Am. J. Pathol. 134:807–811.
Murakami, M., I. Kudo, H. Nakamura, Y. Yokoyama, H. Mori, andK. Inoue. 1990. Exacerbation of rat adjuvant arthritis by intradermal injection of purified 14 kDa group II phospholipase A2.FEBS Lett. 268:113–115.
Peterson, M. W., R. Clark, P. Stone, andD. M. Shasby. 1985. Neutrophil cationic protein increases endothelial albumin transport.Am. Rev. Respir. Dis. 131:A421.
Tetta, C., R. Cosa, andG. Camussi. 1985. Human platelet cationic proteins bind to rat glomeruli, induces loss of anionic charges and increase glomerular permeability.Agents Actions 16:24–26.
Ginsburg, I., R. Borinski, M. Lahav, Y. Matzner, I. Elliasson, P. Christensen, andD. Malamaud. 1985. Poly-l-arginine andN-formylated chemotactic peptides act synergistically with lectins and calcium ionophore to induce intense chemiluminescence and superoxide production by human blood leukocytes.Inflammation 8:1–26.
Ginsburg, I. 1989. Cationic polyelectrolytes: potent opsonic agent which activate the respiratory burst in leucocytes.Free Rad. Res. Commun. 8:11–26.
Antunes, E., M. Mariano, G. Cirino, S. Levi, andG. de Nucci. 1990. Pharmacological characterization of polycation-induced rat hind paw oedema.Br. J. Pharmacol. 101:986–990.
Murakami, M., I. Kudo, andK. Inoue. 1990. In vivo release and clearance of rat platelet phospholipase A2.Biochim. Biophys. Acta 1005:270–276.
Tallarida, R. J., andR. B. Murray. 1987. Manual of Pharmacological Calculations, 2nd ed. Springer-Verlag, New York.
Nachman, R., B. Weksler, andB. Ferris. 1970. Increased vascular permeability produce by human platelet granule cationic extract.J. Clin. Invest. 51:549–552.
Nachman, R. L. 1978.In Platelets, A Multidisciplinary Approach, G. De Gaetano and S. Garattini, editors. Raven Press, New York. 199–201.
Willis, A. L. 1978. Platelet aggregation mechanisms and their implications in haemostasis and inflammatory disease.In Handbook of Experimental Pharmacology. J. R. Vane and S. H. Ferreira, editors. 138–189.
Page, C.P. 1988. The involvement of platelets in non-thrombotic process.Trends Pharmacol. Sci. 9:66–71.
Weksler, B.B. 1988. Platelets.In Inflammation: Basic Principles and Clinical correlates. J. I. Gallin, I. M. Glostein, and R. Synderman, editors. Raven, New York. 543–557.
Virella, G., A. Espinoza, H. Patrick, andJ. A. Colwell. 1982. Polymorphonuclear leucocytes release a factor(s) that induces platelet aggregation and ATP release after interaction with insoluble and surface-fixed immune complexes.Clin. Exp. Immunol. 49:684–688.
Del Maschio, A., V. Evangelista, G. Rajtar, Z. M. Chen, C. Cerletti, andG. De Gaetano. 1990. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agent.Am. J. Physiol. 258:H870-H876.
Chignard, M., M. A. Selak, andJ. B. Smith. 1986. Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin).Proc. Natl. Acad. Sci. U.S.A. 83:8609–8614.
Packham, M. A., E. E. Nishizawa, andJ. F. Mustard. 1968. Response of platelets to tissue injury.Biochem. Pharmacol. 17:171–175.
Skutelsky, E., andD. Danon. 1976. Redistribution of surface anionic sites on the luminal front of blood vessel walls endothelium after interaction with polycationic ligand.J. Cell. Biol. 71:232–241.
Needham, L., P. G. Hellewell, T. J. Williams, andJ. L. Gordon. 1988. Endothelial functional response and increased vascular permeability induced by polycations.Lab. Invest. 59:538–548.
Esmon, C. T., F. B. Taylor, Jr., andT. Russell Snow. 1991. Inflammation and coagulation: Linked processes porentially regulated through a common pathway mediated by protein C.Thromb. Haemostas. 66:160–165.
Cohen, W. M., H. Wu, G. L. Featherstone, J. W. Jenzano, andR. L. Lundblod. 1991. Linkage between blood coagulation and inflammation: Stimulation of neutrophil tissue Kallikrein by thrombin.Biochim. Biophys. Res. Commun. 176:315–320.
Aarsman, A. J., J. Leunissen-Bijvelt, C. D. M. A. Van den Koedijk, F. W. Neys, A. J. Verkleij, andH. Van den Bosch. 1989. Phospholipase A2 activity in platelets. Immunopurification and localization of the enzyme in rat platelets.J. Lip. Med. 1:49–61.
Ginsburg, I., R. Misgav, A. Pinson, J. Varani, P. A. Ward, andR. Kohen. 1992. Synergism among oxidants, phospholipases, microbial hemolysins, cationic proteins and cytokines.Inflammation 16:519–538.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cirino, G., Cicala, C. & Sorrentino, L. Human recombinant platelet phospholipase A2 exacerbates poly-l-arginine induced rat paw edema. Inflammation 18, 59–66 (1994). https://doi.org/10.1007/BF01534598
Issue Date:
DOI: https://doi.org/10.1007/BF01534598